CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapeutics for cancer patients, announced today it will host a conference call and live audio webcast on Monday, November 9, 2015 at 8:00 a.m. ET to report third quarter 2015 financial results and provide a corporate update.
Help employers find you! Check out all the jobs and post your resume.
